I assume it's that doctors would need to disclose that they are using a clinical model that relies on HeraCare and they derive a financial benefit from its use.
Surely given it offers better clinical outcomes that simply disclosing it would not be too problematic.
Ann: Appendix 4D and Half Year Report, page-16
Add HMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.56M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 310082 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 249436 | 1 |
View Market Depth
| Last trade - 10.09am 12/09/2024 (20 minute delay) ? |
| HMD (ASX) Chart |
Day chart unavailable